Skip to main content

Table 5 Comparison of liver and kidney function of patients before, during, and after DC vaccination

From: A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment

Patient

Liver function

Kidney function

GOT/GPT

Bilirubin

Creatinine

Day 0 (before)

Day 36 (during)

Day 57 (after)

Day 0 (before)

Day 36 (during)

Day 57 (after)

Day 0 (before)

Day 36 (during)

Day 57 (after)

1

26/40

40/33

47/37

0.89

1.04

1.35

1.0

1.1

1.0

2

47/38

offa

off

1.15

off

off

0.8

off

off

3

19/14

27/26

54/84

1.0

0.68

0.65

0.8

0.7

0.7

4

38/19

94/37

off

0.95

1.01

off

0.7

0.8

off

5

20/23

17/17

20/39

0.7

1.1

0.5

1.1

1.2

1.0

6

22/9

26/11

22/13

0.9

0.8

1.0

1.2

2.2

2.3

7

24/39

52/55

47/46

0.4

1.2

1.0

1.0

0.9

0.8

8

50/41

132/61

off

1.4

35.5

off

0.8

0.8

off

9

39/15

29/14

41/28

0.4

0.4

0.3

0.5

0.5

0.4

10

32/17

53/30

49/48

0.9

0.8

0.9

0.9

0.8

0.7

11

19/12

20/11

23/14

0.53

0.3

0.33

0.9

0.8

0.8

12

25/24

41/45

28/30

1.5

2.25

1.53

0.9

1.0

1.0

  1. a“off” indicates samples not available for analysis because of withdrawal or termination of enrolled patients from this study